Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the <scp>BLESS</scp> studySimona Lattanzi, Gabriele Camattari, G. D’Orsi et al.|Epilepsia|2025Cited by 18